Personal Genome Diagnostics
Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome using advanced tools and technologies.
$100M Series B+ ·
Led by Cowen Healthcare Investments · Source: startupintros.com
Latest round on record: Series B+, November 2025, amount undisclosed.
Total raised: $123.8M across 3 sourced rounds
All 4 rounds ↓Signals
About Personal Genome Diagnostics
They provide services to oncologists and translational scientists to sequence and analyze cancer genomes and identify mutations. Their expertise includes sample preparation, sequencing, data interpretation, and analysis.
Personal Genome Diagnostics | 4626 days on the record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | — | startupintros.com | |
| Series B+ | $100M | startupintros.com | ||
| Series A | $21M | startupintros.com | ||
| Pre Seed | $2.8M | — | finsmes.com |
Timeline
- Website created
Founders and team
LD
Luis Diaz FounderVV
Victor Velculescu FounderCC
Cindy Caccuro Vice President of Sales- Enterprise SolutionsJD
Jennifer Dickey Vice President of Regulatory and QualityMC
Maria Chan Vice President of Regulatory StrategyMB
Megan Bailey Chief Executive Officer
Investors
CCatalio
CCowen Healthcare Investmentslead investor
IInnovatus Capital Partners
KKern Capital- NNanjing Kaiyuan Growth Capital Investments
NNEAlead investor
NNorthpond Ventures
PPFM Health Sciences
RRock Springs Capital
SSands Capital Ventures
VVensana Capital
WWindham Venture Partners
Companies like Personal Genome Diagnostics
PPhase Scientific$34M Series A · May 2025
EElement Biosciences$175M Series B+ · Jun 2026
SSplice Bio$140M Series B+ · Jun 2025
IInocras$31M Series B+ · Aug 2026
VVariantyx$36M Series B+ · Apr 2024
RRonawkSeries A
Other companies backed by Cowen Healthcare Investments
SStar Therapeutics$200M Series B+ · Oct 2026
TTorl Bio$96M Series B+ · Oct 2025
NNeuron23$97M Series B+ · Jun 2025
FF2G$100M Series B+ · Sep 2024
AAnaveon$120M Series B+ · Dec 2021
Cowen Healthcare Investments portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/personal-genome-diagnostics (get a free API key).